News

Wallstreetcn
2025.11.06 13:57

Eli Lilly's U.S. stock pre-market rose nearly 2% at one point, as the company's new weight loss drug achieved over 20% weight reduction and plans to cooperate with the White House to expand Medicare coverage

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.